Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	calcium ion binding	FAT4 ANXA3 FSTL5 PCDHAC2 PCDHAC1 PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2 LRP1B RYR2 HMCN1 MAN1B1	2.44e-05	749	128	16	GO:0005509
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	FAT4 PCDHAC2 PCDHAC1 PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2 HMCN1 MYPN	1.71e-09	187	126	12	GO:0007156
GeneOntologyBiologicalProcess	cell-cell adhesion via plasma-membrane adhesion molecules	FAT4 PCDHAC2 PCDHAC1 PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2 HMCN1 MYPN TENM1	6.49e-08	313	126	13	GO:0098742
Domain	Cadherin_tail	PCDHAC2 PCDHAC1 PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2	2.65e-12	37	128	9	PF15974
Domain	Cadherin_CBD	PCDHAC2 PCDHAC1 PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2	2.65e-12	37	128	9	IPR031904
Domain	Cadherin	FAT4 PCDHAC2 PCDHAC1 PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2 FREM3	5.21e-10	118	128	11	IPR002126
Domain	Cadherin_2	PCDHAC2 PCDHAC1 PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2	5.81e-10	65	128	9	PF08266
Domain	Cadherin_N	PCDHAC2 PCDHAC1 PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2	5.81e-10	65	128	9	IPR013164
Domain	Cadherin_CS	FAT4 PCDHAC2 PCDHAC1 PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2	3.85e-09	109	128	10	IPR020894
Domain	CADHERIN_1	FAT4 PCDHAC2 PCDHAC1 PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2	5.48e-09	113	128	10	PS00232
Domain	Cadherin	FAT4 PCDHAC2 PCDHAC1 PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2	5.48e-09	113	128	10	PF00028
Domain	CADHERIN_2	FAT4 PCDHAC2 PCDHAC1 PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2	5.97e-09	114	128	10	PS50268
Domain	-	FAT4 PCDHAC2 PCDHAC1 PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2	5.97e-09	114	128	10	2.60.40.60
Domain	CA	FAT4 PCDHAC2 PCDHAC1 PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2	6.50e-09	115	128	10	SM00112
Domain	Cadherin-like	FAT4 PCDHAC2 PCDHAC1 PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2	7.07e-09	116	128	10	IPR015919
Domain	CNH	TNIK MINK1 MAP4K4	1.08e-04	14	128	3	SM00036
Domain	Ank_2	ANKRD39 ASAP1 ASAP2 KANK1 OSBPL1A ANKRD28 TANC1 POTEJ	1.19e-04	215	128	8	PF12796
Domain	CNH	TNIK MINK1 MAP4K4	1.35e-04	15	128	3	PF00780
Domain	CNH	TNIK MINK1 MAP4K4	1.35e-04	15	128	3	PS50219
Domain	CNH_dom	TNIK MINK1 MAP4K4	1.35e-04	15	128	3	IPR001180
Domain	Ank	ANKRD39 ASAP1 ASAP2 KANK1 OSBPL1A ANKRD28 TANC1 POTEJ	1.78e-04	228	128	8	PF00023
Domain	FGF_rcpt_fam	FGFR1 FGFR4	2.77e-04	4	128	2	IPR016248
Domain	-	ANKRD39 ASAP1 ASAP2 KANK1 OSBPL1A ANKRD28 TANC1 POTEJ	3.14e-04	248	128	8	1.25.40.20
Domain	ANK	ANKRD39 ASAP1 ASAP2 KANK1 OSBPL1A ANKRD28 TANC1 POTEJ	3.40e-04	251	128	8	SM00248
Domain	ANK_REPEAT	ANKRD39 ASAP1 ASAP2 KANK1 OSBPL1A ANKRD28 TANC1 POTEJ	3.58e-04	253	128	8	PS50088
Domain	Ankyrin_rpt-contain_dom	ANKRD39 ASAP1 ASAP2 KANK1 OSBPL1A ANKRD28 TANC1 POTEJ	3.68e-04	254	128	8	IPR020683
Domain	ANK_REP_REGION	ANKRD39 ASAP1 ASAP2 KANK1 OSBPL1A ANKRD28 TANC1 POTEJ	3.68e-04	254	128	8	PS50297
Domain	Ankyrin_rpt	ANKRD39 ASAP1 ASAP2 KANK1 OSBPL1A ANKRD28 TANC1 POTEJ	4.52e-04	262	128	8	IPR002110
Domain	Transl_B-barrel	TUFM AARS2 MTIF2	8.15e-04	27	128	3	IPR009000
Domain	Znf_MYM	ZMYM2 ZMYM1	9.57e-04	7	128	2	IPR010507
Domain	zf-FCS	ZMYM2 ZMYM1	9.57e-04	7	128	2	PF06467
Domain	Kinase-like_dom	TNIK MINK1 SIK3 PIK3C2A ROCK1 FGFR1 FGFR4 MAP4K4 EIF2AK3 ALPK2 SOS1	1.27e-03	542	128	11	IPR011009
Domain	TRASH_dom	ZMYM2 ZMYM1	1.27e-03	8	128	2	IPR011017
Domain	TRASH	ZMYM2 ZMYM1	1.27e-03	8	128	2	SM00746
Domain	AIG1	GIMAP5 GIMAP2	1.27e-03	8	128	2	PF04548
Domain	HATC_C_dom	ZBED4 ZMYM1	1.27e-03	8	128	2	IPR008906
Domain	G_AIG1	GIMAP5 GIMAP2	1.27e-03	8	128	2	IPR006703
Domain	Dimer_Tnp_hAT	ZBED4 ZMYM1	1.27e-03	8	128	2	PF05699
Domain	G_AIG1	GIMAP5 GIMAP2	1.27e-03	8	128	2	PS51720
Domain	RNaseH-like_dom	ESRP1 ZBED4 ZMYM1 GEMIN6	1.29e-03	69	128	4	IPR012337
Pubmed	Monoallelic yet combinatorial expression of variable exons of the protocadherin-alpha gene cluster in single neurons.	PCDHAC2 PCDHAC1 PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2	5.28e-19	15	130	9	15640798
Pubmed	Alpha protocadherins and Pyk2 kinase regulate cortical neuron migration and cytoskeletal dynamics via Rac1 GTPase and WAVE complex in mice.	PCDHAC2 PCDHAC1 PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2	2.55e-18	17	130	9	29911975
Pubmed	CNR/Pcdhalpha family in subplate neurons, and developing cortical connectivity.	PCDHAC2 PCDHAC1 PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2	5.08e-18	18	130	9	15570159
Pubmed	Genomic organization of the family of CNR cadherin genes in mice and humans.	PCDHAC2 PCDHAC1 PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2	5.08e-18	18	130	9	10662547
Pubmed	Developmental epigenetic modification regulates stochastic expression of clustered protocadherin genes, generating single neuron diversity.	PCDHAC2 PCDHAC1 PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2	1.34e-16	24	130	9	24698270
Pubmed	Clustered gamma-protocadherins regulate cortical interneuron programmed cell death.	PCDHAC2 PCDHAC1 PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2	8.31e-13	57	130	9	32633719
Pubmed	CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons.	PCDHAC2 PCDHAC1 PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2	9.81e-13	58	130	9	30377227
Pubmed	Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex.	PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA5 PCDHA4	1.10e-12	11	130	6	9655502
Pubmed	Comparative DNA sequence analysis of mouse and human protocadherin gene clusters.	PCDHAC2 PCDHAC1 PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2	4.40e-12	68	130	9	11230163
Pubmed	A striking organization of a large family of human neural cadherin-like cell adhesion genes.	PCDHAC2 PCDHAC1 PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2	7.50e-12	72	130	9	10380929
Pubmed	Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha.	PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2	9.60e-12	28	130	7	15347688
Pubmed	Cadherin superfamily genes: functions, genomic organization, and neurologic diversity.	PCDHAC2 PCDHAC1 PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2	9.68e-12	74	130	9	10817752
Pubmed	Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.	PCDHAC2 PCDHAC1 PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2	1.40e-11	77	130	9	10835267
Pubmed	Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes.	PCDHAC2 PCDHAC1 PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2	1.99e-11	80	130	9	10716726
Pubmed	A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220.	PCDHAC2 PCDHAC1 PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2	7.36e-10	119	130	9	28625976
Pubmed	Genome-wide association for abdominal subcutaneous and visceral adipose reveals a novel locus for visceral fat in women.	PCDHAC2 PCDHAC1 PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2 SIK3	3.28e-09	193	130	10	22589738
Pubmed	Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.	TNIK PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA5 PCDHA2 EPB41L3 ECT2 ASAP1 ASAP2 SOS1	4.47e-09	329	130	12	17474147
Pubmed	The DNA sequence and comparative analysis of human chromosome 5.	PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2	1.39e-08	75	130	7	15372022
Pubmed	Molecular mechanisms governing Pcdh-gamma gene expression: evidence for a multiple promoter and cis-alternative splicing model.	PCDHAC2 PCDHA11 PCDHA5 PCDHA4	2.31e-08	9	130	4	12154121
Pubmed	Comparative interactome analysis of α-arrestin families in human and Drosophila.	TNIK CAD DDX52 ECD ZMYM2 LAMA5 EPB41L3 IPO9 IK MAP4K4 SDCBP	2.96e-08	313	130	11	38270169
Pubmed	Proteins of the CNR family are multiple receptors for Reelin.	PCDHA11 PCDHA7 PCDHA5 PCDHA4	9.01e-08	12	130	4	10612399
Pubmed	Common deletion variants causing protocadherin-α deficiency contribute to the complex genetics of BAV and left-sided congenital heart disease.	PCDHA12 PCDHA10 PCDHA7	5.08e-07	5	130	3	34888534
Pubmed	Feto-maternal cholesterol transport regulated by β-Klotho-FGF15 axis is essential for fetal growth.	APOB LIPC FGFR1 FGFR4	6.92e-07	19	130	4	37541847
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	DNAJB11 CAD DDX52 AGPS EPB41L3 ECT2 PGD GFPT1 TUFM ASAP1 IPO9 SBF1 RDH11 PIK3C2A ANKRD28 TANC1 IK NME7 DYNC1I2	7.14e-07	1353	130	19	29467282
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	COL6A2 STRBP MINK1 SIK3 ECT2 TUFM SBF1 MTIF2 ANKRD28 TANC1 MAP4K4 TOP3A MAN1B1	1.07e-06	650	130	13	38777146
Pubmed	A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.	DDX52 ECD ZMYM2 TUFM PGM3 MED24 IPO9 AARS2 INTS13 ANKRD28 IK DYNC1I2	1.39e-06	560	130	12	35241646
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	COL6A2 DNAJB11 LAMA5 SIK3 AGPS EPB41L3 GFPT1 TUFM AARS2 SBF1 RDH11 AGA MTIF2 EIF4A2 POGLUT2 MAP4K4 FKBP2 CSGALNACT1 MAN1B1	2.00e-06	1451	130	19	30550785
Pubmed	Endogenous Cell Type-Specific Disrupted in Schizophrenia 1 Interactomes Reveal Protein Networks Associated With Neurodevelopmental Disorders.	TNIK EPB41L3 PGM3 IPO9 AARS2 ANKRD28 MAP4K4	2.12e-06	156	130	7	29961565
Pubmed	KAP1 facilitates reinstatement of heterochromatin after DNA replication.	TNIK CAD STRBP DDX52 AGPS GFPT1 TUFM PGM3 AARS2 RDH11 EIF4A2 IK DYNC1I2	2.57e-06	704	130	13	29955894
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TNIK CAD WDR7 MINK1 ZMYM2 SIK3 GRM1 EPB41L3 WDR26 SBF1 EIF4A2 ANKRD28 ROCK1 MAP4K4 SMG6	3.39e-06	963	130	15	28671696
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	DNAJB11 FAT4 STRBP ZMYM2 SIK3 GFPT1 RYR2 IPO9 INTS13 HFM1 POTEJ KNL1	5.28e-06	638	130	12	31182584
Pubmed	Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.	TNIK WDR7 MINK1 SIK3 GRM1 EPB41L3 ASAP1 ASAP2	1.14e-05	281	130	8	28706196
Pubmed	B-lymphoblastic leukemia/lymphoma associated with t(8;13)(p11;q12)/ ZMYM2 (ZNF198)-FGFR1 : rare case and review of the literature.	ZMYM2 FGFR1	1.39e-05	2	130	2	23594707
Pubmed	Characterization of FIM-FGFR1, the fusion product of the myeloproliferative disorder-associated t(8;13) translocation.	ZMYM2 FGFR1	1.39e-05	2	130	2	10480903
Pubmed	FGFR1 is critical for the anti-endothelial mesenchymal transition effect of N-acetyl-seryl-aspartyl-lysyl-proline via induction of the MAP4K4 pathway.	FGFR1 MAP4K4	1.39e-05	2	130	2	28771231
Pubmed	Influence of the -514C/T polymorphism in the promoter of the hepatic lipase gene on postprandial lipoprotein metabolism.	APOB LIPC	1.39e-05	2	130	2	15135253
Pubmed	The oncogenic fusion protein-tyrosine kinase ZNF198/fibroblast growth factor receptor-1 has signaling function comparable with interleukin-6 cytokine receptors.	ZMYM2 FGFR1	1.39e-05	2	130	2	12594223
Pubmed	Association of APOB and LIPC polymorphisms with type 2 diabetes in Chinese Han population.	APOB LIPC	1.39e-05	2	130	2	29883758
Pubmed	Interaction between ApoB and hepatic lipase mediates the uptake of ApoB-containing lipoproteins.	APOB LIPC	1.39e-05	2	130	2	9685400
Pubmed	ZNF198-FGFR1 transforms Ba/F3 cells to growth factor independence and results in high level tyrosine phosphorylation of STATS 1 and 5.	ZMYM2 FGFR1	1.39e-05	2	130	2	10935490
Pubmed	Targeting fibroblast growth factor receptor signaling inhibits prostate cancer progression.	FGFR1 FGFR4	1.39e-05	2	130	2	22573348
Pubmed	PCDHA9 as a candidate gene for amyotrophic lateral sclerosis.	PCDHA12 PCDHA10	1.39e-05	2	130	2	38467605
Pubmed	Role of FGF Receptors and Their Pathways in Adrenocortical Tumors and Possible Therapeutic Implications.	FGFR1 FGFR4	1.39e-05	2	130	2	34956100
Pubmed	Development of ZMYM2-FGFR1 driven AML in human CD34+ cells in immunocompromised mice.	ZMYM2 FGFR1	1.39e-05	2	130	2	27005999
Pubmed	Genetic fingerprinting of the development and progression of T-cell lymphoma in a murine model of atypical myeloproliferative disorder initiated by the ZNF198-fibroblast growth factor receptor-1 chimeric tyrosine kinase.	ZMYM2 FGFR1	1.39e-05	2	130	2	19506298
Pubmed	Ubiquitination of fibroblast growth factor receptor 1 is required for its intracellular sorting but not for its endocytosis.	FGFR1 FGFR4	1.39e-05	2	130	2	18480409
Pubmed	LINC01554-Mediated Glucose Metabolism Reprogramming Suppresses Tumorigenicity in Hepatocellular Carcinoma via Downregulating PKM2 Expression and Inhibiting Akt/mTOR Signaling Pathway.	HIVEP2 PGD TUFM IPO9 HMCN1 EIF4A2	1.64e-05	142	130	6	30809309
Pubmed	Rap2A links intestinal cell polarity to brush border formation.	TNIK MINK1 MAP4K4	2.25e-05	15	130	3	22797597
Pubmed	New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.	FAT4 CAD APOB PGD TUFM TENM1 SPAG17 EIF2AK3 ALPK2 SMG6	2.45e-05	513	130	10	25798074
Pubmed	Yeast two-hybrid screening identified WDR77 as a novel interacting partner of TSC22D2.	ZMYM2 F8 MTIF2 OSBPL1A	2.47e-05	45	130	4	27337956
Pubmed	Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.	TCF3 ZNF423 MINK1 KANK1 FGFR1 TANC1 MAP4K4 SDCBP SMG6 SOS1	3.55e-05	536	130	10	15840001
Pubmed	Exchangeable gene trap using the Cre/mutated lox system.	TCF3 ZNF423 MINK1 KANK1 FGFR1 TANC1 MAP4K4 SDCBP SMG6 SOS1	3.67e-05	538	130	10	10512203
Pubmed	Telencephalic embryonic subtractive sequences: a unique collection of neurodevelopmental genes.	ZNF562 ECT2 PGD ZBED4 ROCK1 SOS1	3.82e-05	165	130	6	16107646
Pubmed	Tagging genes with cassette-exchange sites.	WDR7 STRBP ZNF423 ECT2 EIF4A2 TANC1 ZMYM1 SMG6	4.00e-05	335	130	8	15741177
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	TNIK DNAJB11 CAD ECD MINK1 KIAA1549 SIK3 EPB41L3 PGD SBF1 PIK3C2A MTIF2 ANKRD28 TANC1 NME7 MAP4K4 EIF2AK3	4.11e-05	1487	130	17	33957083
Pubmed	Different clinical significance of FGFR1-4 expression between diffuse-type and intestinal-type gastric cancer.	FGFR1 FGFR4	4.15e-05	3	130	2	28056982
Pubmed	Critical role of STAT5 activation in transformation mediated by ZNF198-FGFR1.	ZMYM2 FGFR1	4.15e-05	3	130	2	14660670
Pubmed	Novel recruitment of Shc, Grb2, and Sos by fibroblast growth factor receptor-1 in v-Src-transformed cells.	FGFR1 SOS1	4.15e-05	3	130	2	9480847
Pubmed	FGFR1 and FGFR4 oncogenicity depends on n-cadherin and their co-expression may predict FGFR-targeted therapy efficacy.	FGFR1 FGFR4	4.15e-05	3	130	2	32114392
Pubmed	Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitors.	FGFR1 FGFR4	4.15e-05	3	130	2	25349422
Pubmed	Identification of two novel PCDHA9 mutations associated with Hirschsprung's disease.	PCDHA12 PCDHA10	4.15e-05	3	130	2	29477871
Pubmed	Fibroblast growth factor receptor 4 is a high affinity receptor for both acidic and basic fibroblast growth factor but not for keratinocyte growth factor.	FGFR1 FGFR4	4.15e-05	3	130	2	7680645
Pubmed	Characterization of the receptor for keratinocyte growth factor. Evidence for multiple fibroblast growth factor receptors.	FGFR1 FGFR4	4.15e-05	3	130	2	2165484
Pubmed	The Genetic Landscape of Hypoplastic Left Heart Syndrome.	PCDHA12 PCDHA10	4.15e-05	3	130	2	29569026
Pubmed	MINK is a Rap2 effector for phosphorylation of the postsynaptic scaffold protein TANC1.	TNIK MINK1	4.15e-05	3	130	2	18930710
Pubmed	The bridging function of hepatic lipase clears plasma cholesterol in LDL receptor-deficient "apoB-48-only" and "apoB-100-only" mice.	APOB LIPC	4.15e-05	3	130	2	14679168
Pubmed	KIAA1549: BRAF Gene Fusion and FGFR1 Hotspot Mutations Are Prognostic Factors in Pilocytic Astrocytomas.	KIAA1549 FGFR1	4.15e-05	3	130	2	26083571
Pubmed	Specificity for fibroblast growth factors determined by heparan sulfate in a binary complex with the receptor kinase.	FGFR1 FGFR4	4.15e-05	3	130	2	10336501
Pubmed	A high-carbohydrate diet effects on the A allele of hepatic lipase polymorphism on the apoB100/apoAI ratio in young Chinese males.	APOB LIPC	4.15e-05	3	130	2	23457133
Pubmed	Constitutive Notch pathway activation in murine ZMYM2-FGFR1-induced T-cell lymphomas associated with atypical myeloproliferative disease.	ZMYM2 FGFR1	4.15e-05	3	130	2	21527531
Pubmed	Decreased expression of FGFR1, SOS1, RAF1 genes in cryptorchidism.	FGFR1 SOS1	4.15e-05	3	130	2	20389169
Pubmed	Microsomal triglyceride transfer protein expression during mouse development.	APOB LIPC	4.15e-05	3	130	2	10744773
Pubmed	ROCK-mediated selective activation of PERK signalling causes fibroblast reprogramming and tumour progression through a CRELD2-dependent mechanism.	ROCK1 EIF2AK3	4.15e-05	3	130	2	32451439
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	CAD IMPDH1 DDX52 MINK1 ZMYM2 LAMA5 ECT2 TUFM MED24 SBF1 PIK3C2A INTS13 TANC1 IK SDCBP MAN1B1 SMG6	4.47e-05	1497	130	17	31527615
Pubmed	Charting the landscape of tandem BRCT domain-mediated protein interactions.	DNAJB11 DDX52 ECT2 WDR26 TULP2 IPO9 EIF4A2 ANKRD28 MAP4K4 FKBP2 DYNC1I2	4.58e-05	670	130	11	22990118
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	DDX52 ESRP1 APOB ASAP1 MED24 INTS13 AGA EIF4A2 MYPN ROCK1 ZMYM1 IK POGLUT2 MAN1B1	5.73e-05	1084	130	14	11544199
Pubmed	Global landscape of HIV-human protein complexes.	DNAJB11 GIMAP5 AGPS IPO9 GEMIN6 IK SDCBP DYNC1I2 SMG6	5.85e-05	457	130	9	22190034
Pubmed	FGFR-4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern.	FGFR1 FGFR4	8.28e-05	4	130	2	1709094
Pubmed	Responsiveness of developing dental tissues to fibroblast growth factors: expression of splicing alternatives of FGFR1, -2, -3, and of FGFR4; and stimulation of cell proliferation by FGF-2, -4, -8, and -9.	FGFR1 FGFR4	8.28e-05	4	130	2	9664689
Pubmed	SSH3 promotes malignant progression of HCC by activating FGF1-mediated FGF/FGFR pathway.	SSH3 FGFR1	8.28e-05	4	130	2	33275222
Pubmed	BetaKlotho is required for metabolic activity of fibroblast growth factor 21.	FGFR1 FGFR4	8.28e-05	4	130	2	17452648
Pubmed	Regulation of renal phosphate transport by FGF23 is mediated by FGFR1 and FGFR4.	FGFR1 FGFR4	8.28e-05	4	130	2	24259513
Pubmed	Point mutation in the fibroblast growth factor receptor eliminates phosphatidylinositol hydrolysis without affecting neuronal differentiation of PC12 cells.	FGFR1 SOS1	8.28e-05	4	130	2	7514169
Pubmed	Differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal human adult tissues.	FGFR1 FGFR4	8.28e-05	4	130	2	9212826
Pubmed	Fibroblast growth factor 21 ameliorates cholestatic liver injury via a hepatic FGFR4-JNK pathway.	FGFR1 FGFR4	8.28e-05	4	130	2	37696161
Pubmed	Expression of fibroblast growth factor receptor family members is associated with prognosis in early stage cervical cancer patients.	FGFR1 FGFR4	8.28e-05	4	130	2	27154171
Pubmed	Association of regions on chromosomes 6 and 7 with blood pressure in Nigerian families.	HDAC9 CPED1	8.28e-05	4	130	2	20031566
Pubmed	Interaction of nebulin SH3 domain with titin PEVK and myopalladin: implications for the signaling and assembly role of titin and nebulin.	MYPN SOS1	8.28e-05	4	130	2	12482578
Pubmed	Immunolocalization of fibroblast growth factor receptors in normal and wounded human skin.	FGFR1 FGFR4	8.28e-05	4	130	2	12373339
Pubmed	FGFR1-4 RNA-Based Gene Alteration and Expression Analysis in Squamous Non-Small Cell Lung Cancer.	FGFR1 FGFR4	8.28e-05	4	130	2	36142417
Pubmed	Shc and a novel 89-kDa component couple to the Grb2-Sos complex in fibroblast growth factor-2-stimulated cells.	FGFR1 SOS1	8.28e-05	4	130	2	7559490
Pubmed	Interaction of POB1, a downstream molecule of small G protein Ral, with PAG2, a paxillin-binding protein, is involved in cell migration.	ASAP1 ASAP2	8.28e-05	4	130	2	12149250
Pubmed	Immunohistochemical detection of fibroblast growth factor receptors in normal endocrine cells and related tumors of the digestive system.	FGFR1 FGFR4	8.28e-05	4	130	2	11759058
Pubmed	The FGF system has a key role in regulating vascular integrity.	FGFR1 FGFR4	8.28e-05	4	130	2	18776942
Pubmed	RNAi-based conditional gene knockdown in mice using a U6 promoter driven vector.	FGFR1 FGFR4	8.28e-05	4	130	2	17304337
Pubmed	Differential expression of fibroblast growth factor receptors in the developing murine choroid plexus.	FGFR1 FGFR4	8.28e-05	4	130	2	12644244
Pubmed	A human MAP kinase interactome.	HDAC9 HIVEP2 ZMYM2 SIK3 EPB41L3 ASAP1 ASAP2 MAP4K4 SOS1	9.34e-05	486	130	9	20936779
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	HIVEP2 KLHDC2 MINK1 SIK3 EPB41L3 ECT2 WDR26 IPO9 SBF1 PIK3C2A TANC1 MAP4K4	9.81e-05	861	130	12	36931259
Pubmed	Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia/reperfusion injury.	COL6A2 APOB FREM3 HMCN1	9.95e-05	64	130	4	22261194
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	STRBP DDX52 ECD APOB EPB41L3 TUFM RYR2 ZBED4 RDH11 EIF4A2 TENM1 FGFR1 POTEJ SPAG17 DYNC1I2 SLC6A14	9.96e-05	1442	130	16	35575683
Interaction	PCDHA10 interactions	PCDHAC1 PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2	6.71e-13	22	129	8	int:PCDHA10
Interaction	PCDHA7 interactions	PCDHA12 PCDHA10 PCDHA7 PCDHA4 PCDHA2	1.90e-08	14	129	5	int:PCDHA7
Interaction	PCDHA8 interactions	PCDHAC2 PCDHA12 PCDHA10 PCDHA7 PCDHA4 PCDHA2 FGFR1	5.87e-08	55	129	7	int:PCDHA8
Interaction	PCDHA11 interactions	PCDHAC2 PCDHA12 PCDHA11 PCDHA10 PCDHA4	1.08e-07	19	129	5	int:PCDHA11
Interaction	PCDHA12 interactions	PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA4 EIF2AK3	4.65e-07	46	129	6	int:PCDHA12
Interaction	FLT3 interactions	STRBP DDX52 PCDHAC2 PCDHAC1 PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2 APOB	9.75e-07	318	129	12	int:FLT3
Interaction	PCDHA9 interactions	PCDHAC2 PCDHA11 PCDHA10 PCDHA7 PCDHA4	1.74e-06	32	129	5	int:PCDHA9
Interaction	PCDHA4 interactions	PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA4 EIF2AK3	2.31e-06	60	129	6	int:PCDHA4
Interaction	PCDHGA10 interactions	PCDHAC1 PCDHA12 PCDHA11 PCDHA4	5.76e-06	19	129	4	int:PCDHGA10
Interaction	NCK2 interactions	TNIK MINK1 ASAP1 ASAP2 SSH3 FGFR1 FGFR4 MAP4K4 SOS1	4.88e-05	262	129	9	int:NCK2
Interaction	CD6 interactions	EPB41L3 ECT2 ZBED4 SBF1 ZMYM1 MAP4K4 SDCBP	6.09e-05	154	129	7	int:CD6
Interaction	EGLN3 interactions	DNAJB11 TCF3 CAD WDR7 ECD SIK3 ECT2 WDR26 GFPT1 TUFM PGM3 SBF1 PIK3C2A INTS13 ANKRD28 GEMIN6 IK MAP4K4 TOP3A DYNC1I2 KNL1	7.37e-05	1296	129	21	int:EGLN3
Interaction	PCDHA2 interactions	PCDHA10 PCDHA7 PCDHA2	8.86e-05	14	129	3	int:PCDHA2
Interaction	CTTNBP2NL interactions	TNIK MINK1 SBF1 ANKRD28 MAP4K4	9.87e-05	72	129	5	int:CTTNBP2NL
Cytoband	5q31	ACSL6 PCDHAC2 PCDHAC1 PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2	1.35e-12	115	130	10	5q31
Cytoband	Ensembl 112 genes in cytogenetic band chr5q31	ACSL6 PCDHAC2 PCDHAC1 PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2 IK	1.05e-09	298	130	11	chr5q31
Cytoband	18q11.1	OSBPL1A ROCK1	4.76e-05	4	130	2	18q11.1
Cytoband	18q21.31	WDR7 ALPK2	9.30e-04	16	130	2	18q21.31
Cytoband	17q21.1	DDX52 MED24	1.46e-03	20	130	2	17q21.1
Cytoband	14q21.3	KLHDC2 DMAC2L	2.67e-03	27	130	2	14q21.3
Cytoband	Ensembl 112 genes in cytogenetic band chr14q21	KLHDC2 TTC6 DMAC2L	2.69e-03	97	130	3	chr14q21
GeneFamily	Clustered protocadherins	PCDHAC2 PCDHAC1 PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2	4.09e-11	64	94	9	20
GeneFamily	Ankyrin repeat domain containing	ANKRD39 ASAP1 ASAP2 KANK1 OSBPL1A ANKRD28 TANC1 POTEJ	3.79e-05	242	94	8	403
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	FSTL5 HMCN1 MYPN FGFR1 FGFR4 ALPK2	1.94e-04	161	94	6	593
GeneFamily	Zinc fingers MYM-type	ZMYM2 ZMYM1	3.96e-04	6	94	2	86
GeneFamily	GTPases, IMAP	GIMAP5 GIMAP2	7.34e-04	8	94	2	580
GeneFamily	X-linked mental retardation\|Rho GTPase activating proteins\|BAR-PH domain containing	ASAP1 ASAP2	3.46e-03	17	94	2	1291
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	ASAP1 ASAP2 SBF1 ROCK1 SOS1	4.42e-03	206	94	5	682
Coexpression	MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED	HSPB3 FSTL5 PCDHAC1 PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2	3.02e-07	238	129	10	M2020
Coexpression	MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED	HSPB3 FSTL5 PCDHAC1 PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2	7.02e-07	261	129	10	MM1277
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 APOB GRM1 LRP1B PKHD1L1 RYR2 HMCN1 TENM1 SPAG17	3.78e-09	184	130	9	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 APOB GRM1 LRP1B PKHD1L1 RYR2 HMCN1 TENM1 SPAG17	3.78e-09	184	130	9	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 APOB GRM1 LRP1B PKHD1L1 RYR2 HMCN1 TENM1 SPAG17	3.78e-09	184	130	9	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	LV-10._Endothelium_II\|World / Chamber and Cluster_Paper	PKHD1L1 F8 ASAP1 SHROOM4 ASAP2 HMCN1 PIK3C2A RIN2	8.08e-08	187	130	8	7876dcb4800c2e54874df3d933efb79307a64a97
ToppCell	RV-10._Endothelium_II\|RV / Chamber and Cluster_Paper	PKHD1L1 F8 ASAP1 SHROOM4 ASAP2 HMCN1 PIK3C2A RIN2	1.03e-07	193	130	8	01c2df9206f1527c578e808978e58196c35e72f5
ToppCell	RV-10._Endothelium_II\|World / Chamber and Cluster_Paper	PKHD1L1 F8 ASAP1 SHROOM4 ASAP2 HMCN1 PIK3C2A RIN2	1.03e-07	193	130	8	2531266bc57339d4e2b22a88817008e32b8c1598
ToppCell	LV-09._Endothelium_I\|LV / Chamber and Cluster_Paper	ANXA3 KIAA1549 F8 ASAP1 SHROOM4 HMCN1 PIK3C2A RIN2	1.21e-07	197	130	8	f9731d4d636e51b94a96805eee6afe9aedc175e3
ToppCell	RA-10._Endothelium_II\|RA / Chamber and Cluster_Paper	PKHD1L1 F8 ASAP1 SHROOM4 HMCN1 PIK3C2A RIN2	1.41e-06	189	130	7	c81787a8c662db5d7814c583dd64562857629e81
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	STRBP ANXA3 ESRP1 ADCY8 TTC6 SHROOM4 KANK1	1.46e-06	190	130	7	8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|RV / Chamber and Cluster_Paper	SIK3 CPED1 RYR2 MYPN TANC1 EIF2AK3 ALPK2	1.46e-06	190	130	7	93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCell	RA-09._Endothelium_I\|World / Chamber and Cluster_Paper	ANXA3 PKHD1L1 F8 ASAP1 SHROOM4 PIK3C2A RIN2	1.51e-06	191	130	7	c8a0c2af119bc34a8f694a7d30642f28002c84b9
ToppCell	droplet-Spleen-nan-18m-Lymphocytic-plasma_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPST1 DNAJB11 DCLRE1B CPED1 AGA FKBP2 MAN1B1	1.57e-06	192	130	7	6417468829517a0f6e04e7e44eec1622001d4c5c
ToppCell	LV-10._Endothelium_II\|LV / Chamber and Cluster_Paper	PKHD1L1 ASAP1 SHROOM4 ASAP2 HMCN1 PIK3C2A RIN2	1.68e-06	194	130	7	b6cc849fa08599bff9839ef382d190cc964e273e
ToppCell	LA-09._Endothelium_I\|World / Chamber and Cluster_Paper	ANXA3 F8 ASAP1 SHROOM4 HMCN1 PIK3C2A RIN2	1.74e-06	195	130	7	fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4
ToppCell	LA-09._Endothelium_I\|LA / Chamber and Cluster_Paper	ANXA3 F8 ASAP1 SHROOM4 HMCN1 PIK3C2A RIN2	1.86e-06	197	130	7	ab6d1ab586a188597a39854ef980b8955ebcc645
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ANXA3 ESRP1 KIAA1549 AGPS GFPT1 TTC6 OSBPL1A	2.06e-06	200	130	7	c450a15e21fa72d071ed6e3b9f22de557a0f3cea
ToppCell	droplet-Kidney-nan-18m-Lymphocytic-CD45____plasma_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPST1 DCLRE1B CPED1 LIPC ALPK2 MAN1B1	1.19e-05	173	130	6	60e427f6c7d953cef5f692043670ff0b49cdce72
ToppCell	PND01-03-samps-Endothelial-Postnatal_endothelial-capillary_endothelial_Hpgd-CA4_high\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	TCF3 IMPDH1 GIMAP5 PCDHAC2 SHROOM4 CSGALNACT1	1.23e-05	174	130	6	cb0109661e8c9ca04d67d33f2d926f0e649bf67d
ToppCell	droplet-Kidney-KIDNEY-30m-Lymphocytic-CD45____plasma_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPST1 DNAJB11 DCLRE1B LIPC FKBP2 MAN1B1	1.36e-05	177	130	6	f0487e3b439f7803e465cad44916e2e271f33d6d
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A2 FAT4 PCDHA10 APOB RYR2 HMCN1	1.54e-05	181	130	6	b116c68393d8836bac080f81a8fcbeb52e0403e7
ToppCell	COVID-19-Heart-CM_3\|Heart / Disease (COVID-19 only), tissue and cell type	TNIK HDAC9 CPED1 RYR2 MYPN ALPK2	1.59e-05	182	130	6	287fcc3897ae08841f6f85ae6c9cef16f75b1dd1
ToppCell	droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ZNF423 KIAA1549 LAMA5 ZDHHC1 SHROOM4 KANK1	1.64e-05	183	130	6	6f8f997ffc9eaebca2683de125b6069d07c07d26
ToppCell	COVID-19-lung-Plasma_cells_PRDM1/BLIMP_int\|lung / Disease (COVID-19 only), tissue and cell type	HDAC9 TCF3 STRBP PGM3 EIF2AK3 KNL1	1.69e-05	184	130	6	480595a0e2e6aa2a77b7daa36490ae3af3d8dfee
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TPST1 DDX52 RIPOR3 TENM1 FGFR1 CSGALNACT1	1.85e-05	187	130	6	c31130fc2f9f882944b2ba366a034a03f051c4b9
ToppCell	10x5'v1-week_17-19-Hematopoietic-MK\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	ANXA3 FAXDC2 RIPOR3 PKHD1L1 RYR2 SHROOM4	1.85e-05	187	130	6	34cad5ac8602fe88ca3d421257190c9a388d4cb0
ToppCell	-Unknown-Endothelial-Myofibroblast\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ZMYM2 CPED1 RYR2 SHROOM4 HMCN1 ZMYM1	1.91e-05	188	130	6	6468fa95ad0395395301115286f2d8c0df5d3882
ToppCell	-Unknown-Endothelial\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ZMYM2 CPED1 RYR2 SHROOM4 HMCN1 ZMYM1	1.91e-05	188	130	6	7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6
ToppCell	-Unknown\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ZMYM2 CPED1 RYR2 SHROOM4 HMCN1 ZMYM1	1.91e-05	188	130	6	9cb718bfe1358c6fd842f096e228eb0abb9aefc6
ToppCell	droplet-Lung-nan-3m-Endothelial-Capillary_Aerocyte_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IMPDH1 ANXA3 PCDHAC2 PCDHAC1 PCDHA10 CSGALNACT1	1.97e-05	189	130	6	7b6cb745c0a637d6addc105a79059ed488fced39
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	CPED1 RYR2 MYPN TANC1 EIF2AK3 ALPK2	1.97e-05	189	130	6	0a82931b5f6c0a6427ca3edd5e2235ac49099d40
ToppCell	facs-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	IMPDH1 ANXA3 PCDHAC2 KIAA1549 PCDHA2 CSGALNACT1	2.02e-05	190	130	6	52213cd2a6a20772d4f49ba9ac0407abafa528db
ToppCell	COVID-19-lung-Vein_EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	HDAC9 FAT4 ZNF423 PKHD1L1 SHROOM4 PIK3C2A	2.02e-05	190	130	6	1caeaef78326734c1e31a0c4739190d5c5a77b9e
ToppCell	facs-Heart-LV-24m-Mesenchymal-ventricular_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACSL6 HSPB3 GRM1 RYR2 MYPN ALPK2	2.09e-05	191	130	6	543da1197c7e62f2c9cbd4a51414bbaaa6d1a92f
ToppCell	facs-Heart-LV-24m-Mesenchymal-ventricular_myocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACSL6 HSPB3 GRM1 RYR2 MYPN ALPK2	2.09e-05	191	130	6	9d7d680da3979e256191b534ebd14c5383e0cf93
ToppCell	LV-04._Ventricular_Cardiomyocyte_I\|LV / Chamber and Cluster_Paper	TNIK CPED1 RYR2 MYPN TANC1 ALPK2	2.15e-05	192	130	6	ad19e2c1d36a0566c9b12ced10db78f4781c8ea6
ToppCell	RA-09._Endothelium_I\|RA / Chamber and Cluster_Paper	ANXA3 PKHD1L1 F8 SHROOM4 PIK3C2A RIN2	2.15e-05	192	130	6	8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 ZNF423 SHROOM4 ASAP2 HMCN1 CSGALNACT1	2.21e-05	193	130	6	6e1982d089a9de628e6006d23ff78a223fbd9f47
ToppCell	Control-Endothelial-Endothelial-Gen_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 ZNF423 SHROOM4 ASAP2 HMCN1 CSGALNACT1	2.21e-05	193	130	6	e1d546165dcc2392f540162206852c4717d7306f
ToppCell	RV-09._Endothelium_I\|World / Chamber and Cluster_Paper	ANXA3 F8 SHROOM4 HMCN1 PIK3C2A RIN2	2.21e-05	193	130	6	e3fa47e2c7cd8a5b69186711c57751f2296de8ae
ToppCell	LPS-IL1RA-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 ZNF423 SHROOM4 ASAP2 TANC1 CSGALNACT1	2.28e-05	194	130	6	43f92b0533e26633dc94cce554045d641ef8fd76
ToppCell	droplet-Lung-nan-18m-Endothelial-Capillary_Aerocyte_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IMPDH1 ANXA3 PCDHAC2 KIAA1549 PCDHA11 CSGALNACT1	2.28e-05	194	130	6	f35f03412b596b6b570b377ba1a607409d984bb1
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 ZNF423 SHROOM4 ASAP2 HMCN1 CSGALNACT1	2.28e-05	194	130	6	0b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCell	LPS-IL1RA-Endothelial-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 ZNF423 SHROOM4 ASAP2 TANC1 CSGALNACT1	2.28e-05	194	130	6	1d39d968730a7e85b6161c1c8a6bd38afe9bcad7
ToppCell	LPS_only-Endothelial\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 ZNF423 SHROOM4 ASAP2 TANC1 CSGALNACT1	2.28e-05	194	130	6	58f069efdefa0366033764446b9d6ffd4a17807e
ToppCell	LPS_only-Endothelial-Endothelial\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 ZNF423 SHROOM4 ASAP2 TANC1 CSGALNACT1	2.28e-05	194	130	6	bfd92ec75facb0ba55c31e5f2e089d983b3d0169
ToppCell	LV-09._Endothelium_I\|World / Chamber and Cluster_Paper	ANXA3 KIAA1549 F8 SHROOM4 HMCN1 RIN2	2.34e-05	195	130	6	19e0a6c3eae1615aaa39767300acd937dfcb2a7f
ToppCell	facs-Lung-18m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	IMPDH1 ANXA3 PCDHAC2 KIAA1549 PCDHA2 CSGALNACT1	2.34e-05	195	130	6	7e0ef92059ff34e368d2324815f49b50e3ca7332
ToppCell	background-Endothelial_cells\|background / Sample and Cell Type and Tumor Cluster (all cells)	F8 ASAP1 SHROOM4 ASAP2 FGFR1 TANC1	2.41e-05	196	130	6	e6fb0bfab1779ec64a8c35d01519eaafbf62e977
ToppCell	facs-Skin-Telogen-3m-Epithelial-bulge_keratinocyte\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A2 KANK1 HMCN1 EIF4A2 FGFR1 SDCBP	2.41e-05	196	130	6	90edf61116ffcb4f8b6be3d0a05732d59b0a87d5
ToppCell	10x3'2.3-week_14-16-Hematopoietic-MK-MK\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	TNIK ANXA3 PKHD1L1 RYR2 ASAP2 RDH11	2.41e-05	196	130	6	66ba31b74953726e9c314f6d8fe3f75d3762e23a
ToppCell	facs-Skin-Telogen-3m-Epithelial-outer_bulge\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A2 KANK1 HMCN1 EIF4A2 FGFR1 SDCBP	2.41e-05	196	130	6	c936014125b2ed5f796221b74acb77b8f8359875
ToppCell	Parenchymal-NucSeq-Endothelial-Endothelia_lymphatic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CYP8B1 ZNF423 PKHD1L1 F8 ASAP1 CSGALNACT1	2.55e-05	198	130	6	9ab0db78394e730f6866b2db80047149024ad5f6
ToppCell	Parenchymal-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CYP8B1 ZNF423 PKHD1L1 F8 ASAP1 CSGALNACT1	2.55e-05	198	130	6	e47d0e2c6353315c85d7007742bb16b0f05795ed
ToppCell	mild-Plasmablast\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TCF3 LAMA5 PKHD1L1 PGM3 EIF2AK3 FKBP2	2.55e-05	198	130	6	b14b9e67815f93fac7bd8e5e6f1aa100951b4ac1
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A2 FAT4 CPED1 HMCN1 TENM1 FGFR1	2.70e-05	200	130	6	b4ccffdd79526c85e5273d27b668dbddcddba1ee
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A2 FAT4 CPED1 RYR2 HMCN1 TENM1	2.70e-05	200	130	6	58b38f9a484ee94191091a0659ed62ebed2d4a14
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-4\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	STRBP LRP1B PKHD1L1 TULP2 EIF2AK3	4.62e-05	134	130	5	8707210b2a5d33baa1d204e9e2ed8921181cb309
ToppCell	severe_COVID-19-NK_CD56bright\|severe_COVID-19 / disease group, cell group and cell class (v2)	FREM3 TANC1 ZMYM1 FGFR4 POGLUT2	1.01e-04	158	130	5	c2e8d96fc29aa2388b92b4fd81d2726e1f7a053f
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRP1B PKHD1L1 ADCY8 RYR2 HMCN1	1.07e-04	160	130	5	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRP1B PKHD1L1 ADCY8 RYR2 HMCN1	1.07e-04	160	130	5	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	356C-Lymphocytic-NK_cells-NK_cell_A2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	HDAC9 KIAA1549 LAMA5 FAXDC2 KNL1	1.10e-04	161	130	5	8ec923c230a7a3cce5edf2a736b3a00d607c698a
ToppCell	ICU-SEP-Lymphocyte-T_NK-MAIT\|ICU-SEP / Disease, Lineage and Cell Type	COL6A2 MINK1 SHROOM4 ZRSR2P1 POGLUT2	1.20e-04	164	130	5	db863a44fc0dad5518c47fdbf64ea21d6f36f089
ToppCell	PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_0\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HSPB3 ANXA3 FAXDC2 PKHD1L1 ASAP2	1.23e-04	165	130	5	6799a6580c667738995cceb31cbf1c7fbdc4ff84
ToppCell	PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_0\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HSPB3 ANXA3 FAXDC2 PKHD1L1 ASAP2	1.23e-04	165	130	5	8329d780f244bc31344443b29e5a00529a016662
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	HDAC9 FAT4 CYP8B1 ZNF423 RIN2	1.31e-04	167	130	5	d7fe24cdc4b55a9555ce9e20699f5036b88148e9
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PKHD1L1 F8 PIK3C2A RIN2 TANC1	1.38e-04	169	130	5	987ff79ad563825dd9877ea8ccb536758f8c6700
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	TNIK GIMAP5 EPB41L3 RIN2 SDCBP	1.38e-04	169	130	5	d4bd489ebdb86e70ed5e3dbbe8518c6cae2197e5
ToppCell	COVID-19-Heart-CM_+_Macrophage\|COVID-19 / Disease (COVID-19 only), tissue and cell type	HDAC9 CPED1 RYR2 MYPN ALPK2	1.42e-04	170	130	5	3f15242a1d3e4e9871d9170b2ef05842fb609c29
ToppCell	ILEUM-non-inflamed-(3)_MNP-(3)_mature_DC\|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	ANXA3 RIPOR3 RIN2 POTEJ MAP4K4	1.46e-04	171	130	5	341f9f79c1ed654ab347e25dc4936f89ffdf9617
ToppCell	facs-Heart-LV-3m-Endothelial-endothelial_cell_of_endocardium\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPED1 PKHD1L1 KANK1 HMCN1 CSGALNACT1	1.50e-04	172	130	5	f2c17c49b375b28ad47dc6cabda62f1c238023dd
ToppCell	facs-Heart-LV-3m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPED1 PKHD1L1 KANK1 HMCN1 CSGALNACT1	1.50e-04	172	130	5	6ab4f01098dddb789df298ddf97b3c384405ee6c
ToppCell	Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	SARM1 FAXC GRM1 ADCY8 MYPN	1.54e-04	173	130	5	7e3897868dd3f6e4974f593c60649a543ffc8693
ToppCell	Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL6A2 CPED1 RYR2 ADRA1D HMCN1	1.54e-04	173	130	5	5416b092321c7d9b63f0418c60f2402a138355bf
ToppCell	facs-Marrow-T_cells-18m-Hematologic-Unknown_Progenitor\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPST1 DNAJB11 FAXC LIPC FKBP2	1.58e-04	174	130	5	3b1ee39e85e5f0d6b17fb3051dbfae66cb2be6ee
ToppCell	droplet-Kidney-nan-18m-Lymphocytic-plasma_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPST1 DCLRE1B CPED1 LIPC MAN1B1	1.58e-04	174	130	5	c92eec5a14ca5269673582dd115ead8516e64c3e
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ANXA3 RIPOR3 APOB SPAG17 ALPK2	1.67e-04	176	130	5	33323c97afe509147956b8df9f92ca6b0537e604
ToppCell	facs-Marrow-B-cells-18m-Hematologic-Unknown_Progenitor\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPST1 ZNF423 CPED1 LIPC FKBP2	1.67e-04	176	130	5	5f9ae5eb45603ed0422a3a993ecdbe2ce05d6e45
ToppCell	Control-Neuronal_cells-Neuronal_cells\|Control / group, cell type (main and fine annotations)	CYP8B1 ZNF423 PKHD1L1 ASAP1 CSGALNACT1	1.67e-04	176	130	5	98c07d26ba0dc0fe15ca0ea81f633d4591782bd1
ToppCell	COVID-19-Heart-CM_3\|COVID-19 / Disease (COVID-19 only), tissue and cell type	HDAC9 CPED1 RYR2 MYPN ALPK2	1.67e-04	176	130	5	9df7a124ebafb0087da0cda133a394275d7bed81
ToppCell	Control-Neuronal_cells\|Control / group, cell type (main and fine annotations)	CYP8B1 ZNF423 PKHD1L1 ASAP1 CSGALNACT1	1.67e-04	176	130	5	c29d09ecf0eb17f767d78af4b7f2e7725c967ff8
ToppCell	356C-Lymphocytic-NK_cells-NK_cell_A2\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	HDAC9 KIAA1549 LAMA5 FAXDC2 KNL1	1.67e-04	176	130	5	052b54c4337ca728974a106b6dbd3b72dd28eb23
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	GIMAP5 F8 PIK3C2A RIN2 MYPN	1.67e-04	176	130	5	64e426f5e84884ce2c29acf6f4b958962a63927f
ToppCell	droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 HMCN1 ZNF408 TANC1 CSGALNACT1	1.71e-04	177	130	5	8ef41ee5d63737b810ad7371b0437625e7e1badf
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7\|TCGA-Colorectal / Sample_Type by Project: Shred V9	HIVEP2 ASAP1 SHROOM4 HMCN1 IK	1.76e-04	178	130	5	edc76b8f15056ec1c9a1c61a048b6331a92592d6
ToppCell	cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A2 CPED1 LRP1B RYR2 MYPN	1.76e-04	178	130	5	8ec2a25dda96c9cc9c2904b6cb18f75a293f4969
ToppCell	cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A2 CPED1 LRP1B RYR2 MYPN	1.76e-04	178	130	5	6c91331196696e0cf239d105f458e3230659fa38
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	HDAC9 FAT4 ZNF423 SHROOM4 RIN2	1.85e-04	180	130	5	27e8bbee388e64dd79d70b160b76d45b1f398006
ToppCell	droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 F8 ASAP1 HMCN1 CSGALNACT1	1.90e-04	181	130	5	4df7972f88117108698efd06b124b232f8588981
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FSTL5 CPED1 ADCY8 TENM1 TANC1	1.90e-04	181	130	5	153709b4dd3d81e09f251fa8765b58bed1932fda
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	HDAC9 CPED1 RYR2 MYPN ALPK2	1.90e-04	181	130	5	719eb532453ab7cd7893726885bc75d74a10b21e
ToppCell	droplet-Liver-hepatocytes-3m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 F8 ASAP1 HMCN1 CSGALNACT1	1.90e-04	181	130	5	cbb530566893281289026bfd93adf721decd4ca3
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SHROOM4 KANK1 RIN2 FGFR1 TANC1	1.95e-04	182	130	5	8a8b08ac4bb3cba3541dbe234e088703842285b9
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SHROOM4 KANK1 RIN2 FGFR1 TANC1	1.95e-04	182	130	5	3cc61f5f7ad4a81eba3daf65e122880b5af3adc0
ToppCell	droplet-Kidney-nan-3m-Endothelial-Pecam____kidney_capillary_endothelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IMPDH1 GIMAP5 ANXA3 F8 ASAP2	1.95e-04	182	130	5	f4a5f1c3a04c0566eb96607dab7a0d9a5ebc3fd1
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SHROOM4 KANK1 RIN2 FGFR1 TANC1	1.95e-04	182	130	5	5d909e4b5f662905bf1be9c686bbddc3e87d2be9
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SHROOM4 KANK1 RIN2 FGFR1 TANC1	1.95e-04	182	130	5	e36766309c4d96a90d213ce37d3acef1029a3fdc
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ANXA3 PCDHA12 FREM3 PKHD1L1 CHST4	2.00e-04	183	130	5	9d5a363fbe6f0a1668c9d584df65ee1c283349c7
ToppCell	ILEUM-inflamed-(5)_IgA_plasma_cells\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	DNAJB11 PKHD1L1 ANKRD28 EIF2AK3 FKBP2	2.00e-04	183	130	5	a113558ca4220bac31f9336033dff82a618d9258
ToppCell	droplet-Kidney-nan-24m-Lymphocytic-CD45____plasma_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPST1 DNAJB11 DCLRE1B LIPC MAN1B1	2.00e-04	183	130	5	edb0069c66b1465dcc0bb5881417c6b17184fd74
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ANXA3 PCDHA12 FREM3 PKHD1L1 CHST4	2.00e-04	183	130	5	c5caac6ed6c8d67f5c336281d9fd903976509445
Drug	dimethyl sulfide	MINK1 PCDHAC2 PCDHAC1 PCDHA12 PCDHA11 ALPK2	7.11e-07	55	130	6	CID000001068
Drug	Dimenhydrinate [523-87-5]; Down 200; 8.6uM; PC3; HT_HG-U133A	TNIK DDX52 LAMA5 KANK1 IPO9 SBF1 SSH3 ZNF408 FGFR1	2.11e-06	198	130	9	6352_DN
Disease	1,5 anhydroglucitol measurement	PCDHAC1 PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2	2.70e-13	29	122	8	EFO_0008009
Disease	visceral adipose tissue measurement, body mass index	PCDHAC2 PCDHAC1 PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2 SIK3	3.07e-12	87	122	10	EFO_0004340, EFO_0004765
Disease	vital capacity	HDAC9 HIVEP2 PCDHAC1 PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2 APOB AGPS WDR26 GFPT1 ADCY8 RYR2 HMCN1 MYPN FGFR4 EIF2AK3 SMG6	3.55e-08	1236	122	21	EFO_0004312
Disease	neutrophil count	TPST1 HIVEP2 CYP8B1 ZNF423 PCDHA12 PCDHA11 PCDHA10 PCDHA7 RIPOR3 PCDHA5 PCDHA4 PCDHA2 DCLRE1B SIK3 WDR26 MED24 OSBPL1A FGFR4 TMCO3 MAP4K4 SMG6	2.30e-07	1382	122	21	EFO_0004833
Disease	lobe attachment	HDAC9 FAT4 HIVEP2 SIK3 GRM1 ADCY8 ASAP1 HMCN1	2.49e-06	207	122	8	EFO_0007667
Disease	pulse pressure measurement	HDAC9 WDR7 ZNF423 PCDHAC1 LAMA5 PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2 ADRA1D ASAP2 PIK3C2A MYPN IK NME7 SMG6	4.47e-06	1392	122	19	EFO_0005763
Disease	neutrophil count, basophil count	PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2	4.23e-05	224	122	7	EFO_0004833, EFO_0005090
Disease	phospholipids in medium HDL measurement	SARM1 APOB SIK3 LIPC	8.06e-05	55	122	4	EFO_0022295
Disease	total lipids in medium HDL measurement	SARM1 APOB SIK3 LIPC	9.93e-05	58	122	4	EFO_0022310
Disease	free cholesterol in medium HDL measurement	SARM1 APOB SIK3 LIPC	9.93e-05	58	122	4	EFO_0022267
Disease	lifestyle measurement, alcohol consumption measurement	CYP8B1 FSTL5 ADCY8 ASAP1 ADRA1D	1.19e-04	115	122	5	EFO_0007878, EFO_0010724
Disease	phospholipids in HDL measurement	SARM1 APOB SIK3 LIPC	1.21e-04	61	122	4	EFO_0022293
Disease	neuroticism measurement, cognitive function measurement	PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2 LRP1B ADCY8 MED24	1.26e-04	566	122	10	EFO_0007660, EFO_0008354
Disease	coronary artery disease, plasminogen activator inhibitor 1 measurement	HDAC9 APOB NME7 SMG6	1.37e-04	63	122	4	EFO_0001645, EFO_0004792
Disease	total lipids in HDL measurement	SARM1 APOB SIK3 LIPC	1.37e-04	63	122	4	EFO_0022307
Disease	bone disease (implicated_via_orthology)	FGFR1 FGFR4	1.68e-04	5	122	2	DOID:0080001 (implicated_via_orthology)
Disease	susceptibility to mononucleosis measurement	HDAC9 FAT4 RYR2 ADRA1D	1.95e-04	69	122	4	EFO_0008403
Disease	post-traumatic stress disorder	PCDHA7 PCDHA5 PCDHA4 PCDHA2 ADCY8 IPO9	2.00e-04	202	122	6	EFO_0001358
Disease	tissue plasminogen activator measurement, coronary artery disease	HDAC9 APOB NME7 SMG6	2.18e-04	71	122	4	EFO_0001645, EFO_0004791
Disease	triacylglycerol 54:3 measurement	SIK3 LIPC MYPN	2.85e-04	31	122	3	EFO_0010421
Disease	ceroid-lipofuscinosis neuronal protein 5 measurement	SARM1 CLN5	3.51e-04	7	122	2	EFO_0802390
Disease	dipeptidyl peptidase 2 measurement	SARM1 MAN1B1	3.51e-04	7	122	2	EFO_0020326
Disease	Pilomyxoid astrocytoma	KIAA1549 FGFR1	3.51e-04	7	122	2	C1519086
Disease	lysophosphatidylethanolamine 18:1 measurement	LRP1B LIPC RIN2	3.76e-04	34	122	3	EFO_0010368
Disease	chylomicron measurement, triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement	APOB SIK3 LIPC	3.76e-04	34	122	3	EFO_0008317, EFO_0008596, EFO_0020947
Disease	post-traumatic stress disorder symptom measurement	PCDHA7 PCDHA5 PCDHA4 PCDHA2	3.79e-04	82	122	4	EFO_0008535
Disease	cholesteryl esters to total lipids in very large HDL percentage	APOB SIK3 LIPC	4.46e-04	36	122	3	EFO_0022257
Disease	cholesteryl esters to total lipids in medium LDL percentage	APOB SIK3 LIPC	4.84e-04	37	122	3	EFO_0022252
Disease	epilepsy (implicated_via_orthology)	TNIK MINK1 LRP1B SBF1 MAP4K4	5.96e-04	163	122	5	DOID:1826 (implicated_via_orthology)
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement, lipid measurement	APOB SIK3 LIPC CSGALNACT1	6.62e-04	95	122	4	EFO_0004529, EFO_0008317, EFO_0008596
Disease	chylomicron measurement, triglyceride measurement, very low density lipoprotein cholesterol measurement	APOB SIK3 LIPC CSGALNACT1	6.89e-04	96	122	4	EFO_0004530, EFO_0008317, EFO_0008596
Disease	level of Triacylglycerol (51:3) in blood serum	APOB SIK3	7.47e-04	10	122	2	OBA_2045163
Disease	triglycerides in large LDL measurement	APOB SIK3 LIPC	7.54e-04	43	122	3	EFO_0022319
Disease	cholesteryl esters to total lipids in small HDL percentage	APOB SIK3 LIPC	7.54e-04	43	122	3	EFO_0022254
Disease	free cholesterol to total lipids in very small VLDL percentage	APOB SIK3 LIPC	7.54e-04	43	122	3	EFO_0022290
Disease	saturated fatty acids measurement	APOB SIK3 LIPC	8.62e-04	45	122	3	EFO_0022304
Disease	cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement	APOB SIK3 LIPC CSGALNACT1	8.97e-04	103	122	4	EFO_0008595, EFO_0020944
Disease	level of Diacylglycerol (18:1_18:1) in blood serum	APOB SIK3	9.10e-04	11	122	2	OBA_2045170
Disease	Cystic Kidney Diseases	DNAJB11 FAT4	9.10e-04	11	122	2	C1691228
Disease	triacylglycerol 54:4 measurement	APOB SIK3 LIPC	9.19e-04	46	122	3	EFO_0010422
Disease	sleep duration, triglyceride measurement	APOB SIK3 LIPC CSGALNACT1	9.30e-04	104	122	4	EFO_0004530, EFO_0005271
Disease	triglyceride measurement, high density lipoprotein cholesterol measurement	SARM1 APOB SIK3 ECT2 LIPC CSGALNACT1	9.98e-04	274	122	6	EFO_0004530, EFO_0004612
Disease	cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement	SARM1 APOB SIK3 LIPC HFM1 CSGALNACT1	1.04e-03	276	122	6	EFO_0004612, EFO_0020943
Disease	Myeloproliferative disease	ZMYM2 FGFR1	1.09e-03	12	122	2	C0027022
Disease	lung adenocarcinoma (is_implicated_in)	LRP1B FGFR4 MAP4K4	1.11e-03	49	122	3	DOID:3910 (is_implicated_in)
Disease	lower face morphology measurement	HDAC9 CPED1 LRP1B SMG6	1.11e-03	109	122	4	EFO_0010948
Disease	triglycerides to total lipids in medium LDL percentage	APOB SIK3 LIPC	1.17e-03	50	122	3	EFO_0022334
Disease	cholesteryl esters to total lipids in IDL percentage	APOB SIK3 LIPC	1.17e-03	50	122	3	EFO_0022247
Disease	coronary artery disease, factor VII measurement	HDAC9 APOB NME7 SMG6	1.18e-03	111	122	4	EFO_0001645, EFO_0004619
Disease	total cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement	APOB SIK3 LIPC	1.24e-03	51	122	3	EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928
Disease	triglycerides to total lipids in large LDL percentage	APOB SIK3 LIPC	1.24e-03	51	122	3	EFO_0022331
Disease	phospholipids in very small VLDL measurement	APOB SIK3 LIPC	1.24e-03	51	122	3	EFO_0022300
Disease	polyunsaturated fatty acids to monounsaturated fatty acids ratio	APOB SIK3 CSGALNACT1	1.24e-03	51	122	3	EFO_0022302
Disease	cholesterol to total lipids in small HDL percentage	APOB SIK3 LIPC	1.24e-03	51	122	3	EFO_0022240
Disease	factor VIII measurement, coronary artery disease	HDAC9 APOB NME7 SMG6	1.27e-03	113	122	4	EFO_0001645, EFO_0004630
Disease	T-cell surface glycoprotein CD3 epsilon chain measurement	SARM1 NME7	1.28e-03	13	122	2	EFO_0802114
Disease	Hyperlipoproteinemia Type IIb	APOB LIPC	1.28e-03	13	122	2	C1704417
Disease	level of Phosphatidylcholine (16:1_18:1) in blood serum	LIPC ROCK1	1.28e-03	13	122	2	OBA_2045082
Disease	gallbladder cancer (is_implicated_in)	APOB LRP1B	1.28e-03	13	122	2	DOID:3121 (is_implicated_in)
Disease	triglycerides in HDL measurement	APOB SIK3 LIPC	1.39e-03	53	122	3	EFO_0022317
Disease	free cholesterol to total lipids in small LDL percentage	APOB SIK3 LIPC	1.39e-03	53	122	3	EFO_0022286
Disease	cholesteryl esters to total lipids in very large VLDL percentage	APOB SIK3 LIPC	1.39e-03	53	122	3	EFO_0022258
Disease	triglycerides in medium HDL measurement	APOB SIK3 LIPC	1.47e-03	54	122	3	EFO_0022321
Disease	cholesterol to total lipids in very large VLDL percentage	APOB SIK3 LIPC	1.47e-03	54	122	3	EFO_0022244
Disease	von Willebrand factor measurement, coronary artery disease	HDAC9 APOB NME7 SMG6	1.48e-03	118	122	4	EFO_0001645, EFO_0004629
Disease	level of Phosphatidylethanolamine (18:1_18:1) in blood serum	SIK3 LIPC	1.49e-03	14	122	2	OBA_2045142
Disease	lysophosphatidylcholine 15:0 measurement	LRP1B LIPC	1.49e-03	14	122	2	EFO_0020941
Disease	serum IgG glycosylation measurement	HIVEP2 ZNF423 LRP1B ADCY8 RYR2 ADRA1D ASAP2 SBF1	1.52e-03	523	122	8	EFO_0005193
Disease	triglycerides in very large HDL measurement	APOB SIK3 LIPC	1.55e-03	55	122	3	EFO_0022324
Disease	triglycerides in large VLDL measurement	APOB SIK3 LIPC	1.63e-03	56	122	3	EFO_0022178
Disease	triglycerides in LDL measurement	APOB SIK3 LIPC	1.63e-03	56	122	3	EFO_0022320
Disease	triglycerides in very large VLDL measurement	APOB SIK3 LIPC	1.63e-03	56	122	3	EFO_0022325
Disease	triglycerides to total lipids in medium HDL percentage	APOB SIK3 LIPC	1.63e-03	56	122	3	EFO_0022333
Disease	triglycerides in chylomicrons and extremely large VLDL measurement	APOB SIK3 LIPC	1.63e-03	56	122	3	EFO_0022316
Disease	cholesterol to total lipids in large LDL percentage	APOB SIK3 LIPC	1.63e-03	56	122	3	EFO_0022235
Disease	cholesteryl esters to total lipids in medium HDL percentage	APOB SIK3 LIPC	1.63e-03	56	122	3	EFO_0022251
Disease	low density lipoprotein triglyceride measurement	APOB LIPC	1.72e-03	15	122	2	EFO_0009946
Disease	triacylglycerol 52:3 measurement	APOB SIK3	1.72e-03	15	122	2	EFO_0010415
Disease	triglycerides to total lipids in chylomicrons and extremely large VLDL percentage	APOB LIPC	1.72e-03	15	122	2	EFO_0022328
Disease	amenorrhea, response to antineoplastic agent	APOB ADCY8	1.72e-03	15	122	2	EFO_0010269, GO_0097327
Disease	triglycerides in IDL measurement	APOB SIK3 LIPC	1.80e-03	58	122	3	EFO_0022149
Disease	angina pectoris	HDAC9 APOB IPO9 SMG6	1.83e-03	125	122	4	EFO_0003913
Disease	triglycerides to total lipids in small LDL percentage	APOB SIK3 LIPC	1.89e-03	59	122	3	EFO_0022337
Disease	cholesterol in medium HDL measurement	APOB SIK3 LIPC	1.89e-03	59	122	3	EFO_0021903
Disease	phospholipids in VLDL measurement	APOB SIK3 LIPC	1.89e-03	59	122	3	EFO_0022301
Disease	triglycerides:total lipids ratio, intermediate density lipoprotein measurement	MINK1 APOB LIPC CSGALNACT1	1.94e-03	127	122	4	EFO_0008595, EFO_0020947
Disease	Hyperlipoproteinemia Type IIa	APOB LIPC	1.96e-03	16	122	2	C0745103
Disease	Abnormality of refraction	PCDHAC1 PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2 ASAP1	1.97e-03	673	122	9	HP_0000539
Disease	phospholipids in small VLDL measurement	APOB SIK3 LIPC	1.99e-03	60	122	3	EFO_0022146
Disease	triglycerides to total lipids in large HDL percentage	APOB SIK3 LIPC	1.99e-03	60	122	3	EFO_0022330
Disease	cholesterol to total lipids in IDL percentage	APOB SIK3 LIPC	1.99e-03	60	122	3	EFO_0022233
Disease	esterified cholesterol measurement	APOB SIK3 ASAP2 LIPC	2.00e-03	128	122	4	EFO_0008589
Disease	free cholesterol measurement, high density lipoprotein cholesterol measurement	SARM1 APOB SIK3 LIPC CSGALNACT1 KNL1	2.03e-03	315	122	6	EFO_0004612, EFO_0008591
Disease	triglycerides in small VLDL measurement	APOB SIK3 LIPC	2.08e-03	61	122	3	EFO_0022145
Disease	free cholesterol in VLDL measurement	APOB SIK3 LIPC	2.08e-03	61	122	3	EFO_0022276
Disease	free cholesterol in HDL measurement	APOB SIK3 LIPC	2.08e-03	61	122	3	EFO_0022264
Disease	choline measurement	SARM1 APOB SIK3 LIPC	2.12e-03	130	122	4	EFO_0010116
Disease	triglycerides in small HDL measurement	APOB SIK3 LIPC	2.18e-03	62	122	3	EFO_0022158
Disease	triglycerides in medium LDL measurement	APOB SIK3 LIPC	2.18e-03	62	122	3	EFO_0022322
Disease	triglycerides to total lipids in very large HDL percentage	APOB SIK3 LIPC	2.18e-03	62	122	3	EFO_0022339

Protein segments in the cluster

Peptide	Gene	Start	Entry
LHHEEMIGKAGGVSL	TPST1	266	O60507
HMFHIEGAQRLGSIA	NT5C1B	586	Q96P26
KHDVDMRIGIHSGSV	ADCY8	501	P40145
FLHAHGKLFTRIGME	SMG6	896	Q86US8
KISEGTGFRIHMIHK	DDX52	256	Q9Y2R4
AGFRTKAEHLDHVMF	PGM3	26	O95394
EASHGQLGMLVFRHE	CSGALNACT1	501	Q8TDX6
IAEAVEFLHSKGLMH	EIF2AK3	921	Q9NZJ5
ESMETHFGSHGRRAI	CPED1	86	A4D0V7
GEGVHRKAFRSTVMH	ALPK2	1926	Q86TB3
MKKVSDGHFHTVIAR	FAT4	4051	Q6V0I7
MKIADFGLARGVHHI	FGFR4	626	P22455
DLKGDLSGHFEHLMV	ANXA3	71	P12429
HAAFSGHGEMVKLLL	ANKRD28	146	O15084
DEGAGHFVKMVHNGI	PGD	176	P52209
HMEDGFHGVLRTIDM	AADACL3	371	Q5VUY0
MTSLHKAAERGHGDI	ANKRD39	131	Q53RE8
GFDHMEGLEHVEKIR	DMAC2L	116	Q99766
TVEEKAGRIHAVDHM	DCLRE1B	221	Q9H816
RAHELGMKLAHGFEI	ECD	296	O95905
GEFATDIRTHGVHMV	ESRP1	466	Q6NXG1
HVMVAAGTKLFIHGG	RABEPK	196	Q7Z6M1
VTLVHHMGGVIRKDF	ECT2	196	Q9H8V3
KVISHMLSSHGGEIF	INTS13	371	Q9NVM9
RAGMHSSVHLEEAGI	PCDHA2	811	Q9Y5H9
GLMTALFEVRKHHQG	KIAA1549	1071	Q9HCM3
AGMHSSVHLEEAGIL	PCDHA7	801	Q9UN72
IVKREMHGHGIGRFS	FAXC	241	Q5TGI0
LRAGMHSSVHLEEAG	PCDHA11	811	Q9Y5I1
VETGHLDGVFMHKRA	MAP4K4	1186	O95819
IEFSNMDGSHRHKVP	LRP1B	3196	Q9NZR2
VLHMHYTGKLEDGTE	FKBP2	51	P26885
MGHVDHGKTTLLDKF	MTIF2	186	P46199
EHAKLHGMIRTEISG	ASAP2	166	O43150
RHGSKAGISEMFEGH	DYNC1I2	461	Q13409
IKAQHGTRMDEHGFI	HSPB3	96	Q12988
TVMGLSFIHRFGKHA	OR51B4	251	Q9Y5P0
IMLRSTGHMFHIDFG	PIK3C2A	1256	O00443
MAEGHHAVNIEGLKS	KANK1	1046	Q14678
HTFTREHMGLSVGIK	LIPC	221	P11150
ADKIHITRSHIMGAE	KNL1	406	Q8NG31
MSFEKAVEHGAHGLE	GDPD4	216	Q6W3E5
IGEHLHAGMSTLFLV	F8	2021	P00451
KEEGGRHKPFVSHFM	TUFM	361	P49411
TADLLVGRAMTFHGH	LAMA5	3116	O15230
GMHSSVHLEEAGILR	PCDHA5	801	Q9Y5H7
EEEGEHLGSRKHRMS	OSBPL1A	501	Q9BXW6
GELAHGRFSAKMDHL	MAN1B1	511	Q9UKM7
THMRFGFILHKDEAA	FSTL5	611	Q8N475
KGGSTMLVDGEHHVS	HMCN1	1206	Q96RW7
TVGDVLEAKMRHGFS	IMPDH1	126	P20839
ESGVTSDHLKGLHVM	SBF1	841	O95248
RAGMHSSVHLEEAGI	PCDHA10	811	Q9Y5I2
GAMRHVVILFTHKED	GIMAP5	141	Q96F15
HHAGMELSDRKVVEG	HFM1	586	A2PYH4
RAGMHSSVHLEEAGI	PCDHAC1	826	Q9H158
AGMHSSVHLEEAGIL	PCDHAC2	871	Q9Y5I4
AGMHSSVHLEEAGIL	PCDHA4	811	Q9UN74
GVLDHLHGTDTMFKQ	FAXDC2	291	Q96IV6
HVGHSVLTAKGMALF	APOB	2996	P04114
DAMGHTIVLFTHKED	GIMAP2	136	Q9UG22
VMKIADFGLARDIHH	FGFR1	636	P11362
AIGIGDMFHEKHESE	COL6A2	756	P12110
EHAKQHGMIRTEITG	ASAP1	186	Q9ULH1
VKMVGHHVAFLEADV	BCAS4	121	Q8TDM0
VGFEMDITHLDGHKV	DNAJB11	271	Q9UBS4
EKMHARDFTVSALHG	EIF4A2	291	Q14240
DRGHDTIGMVVIHKT	AGA	201	P20933
ITDSVKNGRIHFDMH	IPO9	461	Q96P70
ERSGHVAVSDGRHMF	KLHDC2	31	Q9Y2U9
GMDGLEKHRLVSRTH	HDAC9	596	Q9UKV0
MDGDVIIGALFSVHH	GRM1	41	Q13255
HRVREKLMHLFTSGD	GEMIN6	76	Q8WXD5
ERTITMHKDSTGHVG	SDCBP	196	O00560
SDFEVLMKTAHGHLV	RYR2	1341	Q92736
HHAKDSEGVEIMLGV	EPB41L3	301	Q9Y2J2
GDGSVEMHDVKNHRT	NME7	31	Q9Y5B8
EMIHSASTKHLRGDG	CYP8B1	121	Q9UNU6
GMHSSVHLEEAGILR	PCDHA12	806	Q9UN75
SMGHQATGTVRKDHI	PGBD3	366	Q8N328
IRSVETGHLDGVFMH	MINK1	1276	Q8N4C8
TGHLDGVFMHKRAQR	MINK1	1281	Q8N4C8
TMRGAGAVIHTHSKA	APIP	106	Q96GX9
LKRLHTGHMGFLITS	FREM3	1671	P0C091
SKTADGFEMHIGVNH	RDH11	136	Q8TC12
ADHHFIKDIVTIGML	TMCO3	266	Q6UWJ1
TYMHSEGILAGELKH	GFPT1	581	Q06210
SRSIHIFDTLLHMGG	MED24	726	O75448
AIEEMKKHGSTHVGF	POTEJ	501	P0CG39
FDHLVAHGRMAEKEA	SIK3	151	Q9Y2K2
LQHVHLDTRGSKGME	SHROOM4	421	Q9ULL8
VEKGAVIEHVDHSGM	TANC1	1231	Q9C0D5
SGVIKTIHLMHDGFI	TENM1	1996	Q9UKZ4
SETGGSHDKRFVMEV	STRBP	531	Q96SI9
MEGTLTRVGAKHERH	SOS1	446	Q07889
VGRDLSHHTFFEMLG	AARS2	121	Q5JTZ9
GAKGSAHISHNIEIM	SPAG17	2151	Q6Q759
GTHVLVHCKMGVSRS	SSH3	406	Q8TE77
DGAHGMRSAKGHTFR	ADRA1D	316	P25100
HHFIMGSEGTLGVIT	AGPS	361	O00116
EDMVRLGKESGLHSF	ACSL6	636	Q9UKU0
GHLKIMHDAIGFRST	CLN5	111	O75503
VHNITRGKGMGDHAF	CHST4	306	Q8NCG5
THSMVRHKDGGYSEE	RIN2	51	Q8WYP3
FASLDNHMGIHIGEK	ZNF562	216	Q6V9R5
SVETGHLDGVFMHKR	TNIK	1306	Q9UKE5
ALKGEGGTDSDHMRH	TULP2	241	O00295
LTNRGVIHEFMGHKQ	TTC6	351	Q86TZ1
ALEVHLGEFHIRMKG	RIPOR3	196	Q96MK2
ARSVAGILEHMFKHS	SARM1	181	Q6SZW1
IHVLRSHAVGTAGDM	TCF3	401	P15923
SSEESFKAHMLGHRG	ZNF408	391	Q9H9D4
KFLGGDMEHTHLVKG	IK	151	Q13123
MIDVDGSLTGHKGHT	PKHD1L1	2796	Q86WI1
IKTHGEHVGFRIFMD	POGLUT2	201	Q6UW63
TMVGDLKHGRTVHSL	CAD	2076	P27708
LMEKHGIGTDATHAE	TOP3A	526	Q13472
LDAIHSMGFIHRDVK	ROCK1	186	Q13464
GSHPSFLKEVRDHMQ	ZMYM2	506	Q9UBW7
LGSFQIHMKRHTGDR	ZNF563	321	Q8TA94
SFGKNSERREKMGHH	ZRSR2P1	361	Q15695
HLIEHSFEGMGGTFK	ZNF423	1216	Q2M1K9
GFVDTEEMTGTHLHR	ZMYM1	681	Q5SVZ6
EHPSATKFRNHVMEG	WDR26	156	Q9H7D7
VEVEHHGRMLKGISS	HIVEP2	606	P31629
FSILGHMAHISGKEV	SLC6A14	366	Q9UN76
SGEMKHIFCVHGGEI	WDR7	501	Q9Y4E6
MGAIFAGHLVVHLTA	ZDHHC1	86	Q8WTX9
MIGRHHVTDVLSGFV	PLPP7	231	Q8NBV4
IMSHLKEAESGVIHF	ZBED4	716	O75132
DASHKMLVRETGVHS	MYPN	1116	Q86TC9